We are live on ! Find out more
PDM

Penn Davis McFarland Portfolio holdings

AUM $1.12B
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+32.35%
3 Year Est. Return
+86.8%
5 Year Est. Return
+114.42%
10 Year Est. Return
+392.43%
AUM
$337M
AUM Growth
+$17.5M
Cap. Flow
-$10.1M
Cap. Flow %
-3%
Top 10 Hldgs %
67.81%
Holding
53
New
9
Increased
13
Reduced
16
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$11.6M
2
UNH icon
UnitedHealth
UNH
+$5.14M
3
ATVI
Activision Blizzard
ATVI
+$3.68M
4
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$936K
5
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
+$532K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$20.9M
2
GILD icon
Gilead Sciences
GILD
+$7.58M
3
NLSN
Nielsen Holdings plc
NLSN
+$2.28M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$529K
5
NBL
Noble Energy, Inc.
NBL
+$410K

Sector Composition

Rank Sector Weight
1 Technology 27.75%
2 Energy 17.25%
3 Communication Services 16.89%
4 Healthcare 13.49%
5 Industrials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DMLP icon
26
Dorchester Minerals
DMLP
$1.32B
$743K 0.22%
38,080
-6,950
-15% -$125K
BMY.RT
27
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$615K 0.18%
+204,438
New +$532K
AMZN icon
28
Amazon
AMZN
$2.69T
$516K 0.15%
5,580
+2,000
+56% +$177K
PAYX icon
29
Paychex
PAYX
$41B
$500K 0.15%
5,881
+281
+5% +$23.7K
AMGN icon
30
Amgen
AMGN
$198B
$377K 0.11%
1,564
+64
+4% +$14.1K
SPY icon
31
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$336K 0.1%
1,045
+1
+0.1% +$308
DISH
32
DELISTED
DISH Network Corp.
DISH
$301K 0.09%
8,500
– –
CVX icon
33
Chevron
CVX
$378B
$296K 0.09%
2,453
– –
MSFT icon
34
Microsoft
MSFT
$2.98T
$274K 0.08%
+1,740
New +$256K
PEP icon
35
PepsiCo
PEP
$183B
$266K 0.08%
+1,944
New +$265K
CSCO icon
36
Cisco
CSCO
$439B
$256K 0.08%
5,345
+158
+3% +$7.34K
BRK.B icon
37
Berkshire Hathaway Class B
BRK.B
$1.06T
$255K 0.08%
1,125
– –
NVDA icon
38
NVIDIA
NVDA
$4.92T
$235K 0.07%
+40,000
New +$208K
JPM icon
39
JPMorgan Chase
JPM
$904B
$230K 0.07%
+1,652
New +$212K
ET icon
40
Energy Transfer Partners
ET
$70B
$228K 0.07%
17,733
– –
XOM icon
41
ExxonMobil
XOM
$617B
$228K 0.07%
3,269
– –
PFE icon
42
Pfizer
PFE
$142B
$226K 0.07%
6,072
+200
+3% +$7.12K
BSM icon
43
Black Stone Minerals
BSM
$3.04B
$223K 0.07%
17,529
– –
MRK icon
44
Merck
MRK
$310B
$209K 0.06%
+2,410
New +$198K
UNP icon
45
Union Pacific
UNP
$178B
$205K 0.06%
+1,134
New +$194K
RTN
46
DELISTED
Raytheon Company
RTN
$203K 0.06%
+925
New +$196K
BLDP
47
Ballard Power Systems
BLDP
$793M
$87K 0.03%
12,150
– –
ACH
48
Accendra Health
ACH
$257M
$62K 0.02%
12,000
– –
AEG icon
49
Aegon
AEG
$13.4B
– –
-24,927
Closed -$95K
GE icon
50
GE Aerospace
GE
$353B
– –
-3,662
Closed -$163K
1
2
3

Similar funds

EC
Estate Counselors Thiensville, Wisconsin $1.12B AUM 20.13% 1-Year Est. Return
JLBC
J.L. Bainbridge & Co Sarasota, Florida $1.12B AUM 25.58% 1-Year Est. Return
WA
Wealth Architects Mountain View, California $1.12B AUM 24.94% 1-Year Est. Return
FBFS
First Business Financial Services Madison, Wisconsin $1.12B AUM 22.16% 1-Year Est. Return
JAFL
Jay A. Fishman Ltd Troy, Michigan $1.12B AUM 32.75% 1-Year Est. Return
SL
Salomon & Ludwin Richmond, Virginia $1.12B AUM 14.38% 1-Year Est. Return
PTC
Private Trust Company Cleveland, Ohio $1.12B AUM 21.35% 1-Year Est. Return
CT
Caldwell Trust Venice, Florida $1.12B AUM 21.31% 1-Year Est. Return

Penn Davis McFarland's Q4 2019 Portfolio in Review

As of Q4 2019, Penn Davis McFarland held 53 positions worth $337M, up 5.5% from $320M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Penn Davis McFarland's Q4 2019 filing shows 9 new, 13 increased, 16 reduced and 4 closed positions. Its largest new stake was Reata Pharmaceuticals, Inc. Class A Common Stock: 5,131 shares worth $1.05M. The largest sale was Celgene Corp, an estimated $20.9M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Energy and Communication Services.

  • Penn Davis McFarland's largest Q4 2019 buy was Reata Pharmaceuticals, Inc. Class A Common Stock: 5,131 shares worth $1.05M.
  • Penn Davis McFarland added most to Bristol-Myers Squibb in Q4 2019, an estimated $11.6M increase.
  • Penn Davis McFarland's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $7.58M.
  • Penn Davis McFarland fully exited Celgene Corp in Q4 2019, selling an estimated $20.9M.
  • Penn Davis McFarland's ten largest holdings make up 68% of its $337M portfolio in Q4 2019.
  • Penn Davis McFarland opened 9 new positions and closed 4 in Q4 2019.
  • Penn Davis McFarland's portfolio value rose 5.5% quarter-over-quarter to $337M.

Based on Penn Davis McFarland's 13F filing for Q4 2019, filed 17 Jan 2020.